CPQuali Pesquisa Clínica
CPQuali Pesquisa Clínica
Avenida Angélica, 916 Conjunto 506 - São Paulo 01228-000
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Mariane Escudeiro
Vitoria Nelo
Gustavo Fagundes
Karina Forlenza
Rafael Paterno Castello Dias Carneiro
Pedro Kurita
João Paulo Ramos
Maria Tereza Martinez
Renata Canovas
Luiza Villarim
Carolina Perniquelli
Moacyr Alexandre Rosa
Luciana Anzei
Ingrid Silva
Mauricio Sa Oliveira
Natali Maia
Giovanna Milinkovic
Marcelo Cardoso
Elizangela Fernandes Nogueira
Fabiola Franco Godoi
Rafaela Ribas
Maria Elisangela de Sousa
Monica Daniel Souza
Rosemar Joaquim da Silva
Barbara Silveira
Julia Silveira
Diogo Haddad Santos
Flavia Timbo Albuquerque
Mariana Correa de Souza
Vitoria Giovanna Sampaio
Milena Failla Preti
Ana Laura Carneiro Parizi
Maryane Sena
Rafael Paterno Castello Dias Carneiro
Open studies
Obesity
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels - REDEFINE 3 - Novo Nordisk A/SSee more
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
Cardiovascular disease
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels - REDEFINE 3 - Novo Nordisk A/SSee more
Depression
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy - VENTURA-1 - Janssen Research & Development, LLCSee more
Diabetes
A Research Study to See How Much CagriSema (1.0 mg Once Weekly) Lowers Blood Sugar and Body Weight Compared to Tirzepatide (5 mg Once Weekly) in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both - REIMAGINE 5 - Novo Nordisk A/SSee more
Multiple sclerosis
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis - FREVIVA - SanofiSee more
Schizophrenia
Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) - CONNEX-1 CONNEX-2 CONNEX-3 - Boehringer IngelheimSee more
